ENTITY
CSPC Pharmaceutical

CSPC Pharmaceutical (1093 HK)

519
Analysis
Health Care • China
CSPC Pharmaceutical Group Limited is a prominent Chinese pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products, including innovative drugs and bulk drugs. Its key products include innovative drugs for nervous system diseases, oncology, anti-infectives, and cardiovascular diseases, as well as bulk products like vitamin C, antibiotics, and caffeine. The company was formally established in 1997 and is headquartered in Shijiazhuang, Hebei Province, China.
more
•05 Feb 2015 16:01

Introducing Long Term Leaders - Focussed Insights for your Core Holdings

We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category,  we have identified companies that...

Logo
497 Views
Share
bullish•Quantitative Analysis
•15 Mar 2026 10:05

HK Connect Flows Weekly (Mar 13th): Tencent, CNOOC, Jiaxin International Resourc, Lingbao Gold

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Tencent (700 HK), CNOOC (883 HK), Jiaxin International...

Logo
219 Views
Share
bearish•Quantitative Analysis
•08 Mar 2026 10:10

HK Short Interest Weekly: YOFC, Alibaba, HSBC, Sensetime, AIA, Techtronic, China Life

We analyzed the latest HK SFC report for aggregate short position as of Feb 27th and highlight short interest changes in YOFC, Alibaba, HSBC,...

Logo
375 Views
Share
bullish•Quantitative Analysis
•08 Mar 2026 10:05

HK Connect Flows Weekly (Mar 6th): Alibaba, Tencent, China Life, Xiaomi, Petrochina, ICBC

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Alibaba (9988 HK), Tencent (700 HK), China Life (2628...

Logo
253 Views
Share
•05 Mar 2026 08:30

Sino Biopharma (1177 HK): Rovadicitinib Approved for Marketing, Outlicensing Agreement with Sanofi

​Sino Biopharmaceutical received approval for rovadicitinib tablet for myelofibrosis and signs outlicensing agreement with Sanofi. Aims for over...

Logo
392 Views
Share
x